Receiving monoclonal antibodies to treat COVID-19 used to be a time-consuming process at the UPMC Hamot Infusion Center. The intravenous treatment took about 30 minutes, which came after a nearly hour ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. New research suggests that the casirivimab-imdevimab monoclonal antibody treatment for COVID-19 ...

While administering monoclonal antibodies via intravenous infusion is standard practice to prevent severe hospitalization and death in outpatients with COVID-19, new research from UPMC shows giving ...

WASHINGTON - The U.S. Food and Drug Administration has cleared a formulation of the COVID-19 antibody drug made by Regeneron Pharmaceuticals Inc. that can be injected, rather than administered by IV ...

The Food and Drug Administration (FDA) has authorized Regeneron’s COVID-19 antibody drug for injections. Regeneron said in a statement on Friday that the agency updated the emergency use authorization ...

(Reuters) -Britain's GSK and partner Vir said on Friday their antibody-based COVID-19 drug was shown in a trial to work as well when given as a shot in the arm awhen administered via the standard ...

A new monoclonal antibody treatment has been found to protect chronically ill adults from developing COVID-19. The Phase 3 trial results suggest the novel antibody cocktail, delivered by intramuscular ...

RALEIGH, N.C. (WTVD) -- Katherine Wall and her whole family got COVID-19 in January before vaccines were readily available. She said she has an underlying autoimmune disease and got really sick. "I ...

June 4 (Reuters) - The U.S. health regulator authorized a lower dose of Regeneron Pharmaceutical’s COVID-19 antibody cocktail that can be given by injection, a move that could ease logistical ...

Antibody infusions a 'game-changer' in fight against Covid From left, Melissa Edmister, Jesse Arneson and Leah Scaramuzzo at Logan Health Medical Center on Nov. 9, 2021. (Matt Baldwin/Daily Inter Lake ...

Nov 12 (Reuters) - Britain's GSK (GSK.L), opens new tab and partner Vir (VIR.O), opens new tab said on Friday their antibody-based COVID-19 drug was shown in a trial to work as well when given as a ...

U.S. health regulators have authorized newer, more convenient forms of a Covid-19 antibody drug made by Regeneron Pharmaceuticals Inc.REGN0.49%increase; green up pointing triangle that could make it ...